Skip to main content

Table 2 The pharmacokinetic parameters of LC/MS/MS.

From: Controlled release of Clenbuterol from a hydroxyapatite carrier for the treatment of Alzheimer’s Disease

 

Cmax (ng/mL)

Tmax (hr)

AUC0 − t (ng/mL*hr)

AUC0 − inf (ng/mL*hr)

Time start (hr)

Time end (hr)

CLB

120.19

4.0

4886.43 ± 3744.95

5199.55 ± 4003.23

0.5

168

SHAP-CLB

156.24

4.0

5390.80 ± 4480.44

7361.66 ± 4370.81

0.5

168

Back to article page

Biomaterials Research

ISSN: 2055-7124

Contact us